News
A Message From Our CEO
November 2, 2020
The CF Foundation has successfully completed a sale of its remaining stake in royalties related to Vertex’s CFTR modulators for an upfront payment of $575 million and a potential future payment of $75 million, bringing additional resources to the fight against CF.